Long-term results of a phase II trial of lenalidomide plus prednisone therapy for patients with myelofibrosis

Lenalidomide, with or without prednisone, is an active therapy for patients with myelofibrosis (MF). We provide an update of a phase II study of lenalidomide plus prednisone in patients with MF, after median follow up of 9 years. Forty patients were enrolled in the study and all patients were evalua...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Leuk Res
Main Authors: Chihara, Dai, Masarova, Lucia, Newberry, Kate J., Maeng, Hoyoung, Ravandi, Farhad, Garcia-Manero, Guillermo, Ferrajoli, Alessandra, Cortes, Jorge, Kantarjian, Hagop, Verstovsek, Srdan
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5407688/
https://ncbi.nlm.nih.gov/pubmed/27416326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2016.06.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados